Aminoglycoside resistance in enterococci.

作者: J. W. Chow

DOI: 10.1086/313949

关键词:

摘要: High-level aminoglycoside resistance in enterococci is mediated generally by aminoglycoside-modifying enzymes, which eliminate the synergistic bactericidal effect usually seen when a cell wall-active agent combined with an aminoglycoside. Clinical microbiology laboratories currently screen for testing gentamicin and streptomycin susceptibility. If recently detected genes, aph(2")-Ib, aph(2")-Ic, aph(2")-Id, become more prevalent among clinical isolates, approach detecting susceptibility to synergism will require modification. More potent aminoglycosides need be developed that resistant modification broad spectrum of enzymes present enterococci.

参考文章(26)
Robert C. Moellering, Arnold N. Weinberg, Studies on antibiotic synergism against enterococci: II. Effect of various antibiotics on the uptake of 14C-labeled streptomycin by enterococci Journal of Clinical Investigation. ,vol. 50, pp. 2580- 2584 ,(1971) , 10.1172/JCI106758
Donald J. Krogstad, Thomas R. Korfhagen, Robert C. Moellering, Christine Wennersten, Morton N. Swartz, Stanislaw Perzynski, Julian Davies, Aminoglycoside-Inactivating Enzymes in Clinical Isolates of Streptococcus Faecalis Journal of Clinical Investigation. ,vol. 62, pp. 480- 486 ,(1978) , 10.1172/JCI109149
G M Eliopoulos, B F Farber, B E Murray, C Wennersten, R C Moellering, Ribosomal resistance of clinical enterococcal to streptomycin isolates. Antimicrobial Agents and Chemotherapy. ,vol. 25, pp. 398- 399 ,(1984) , 10.1128/AAC.25.3.398
M K Hayden, G I Koenig, G M Trenholme, Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations. Antimicrobial Agents and Chemotherapy. ,vol. 38, pp. 1225- 1229 ,(1994) , 10.1128/AAC.38.6.1225
R. C. Moellering, B. E. Murray, S. C. Schoenbaum, J. Adler, C. B. Wennersten, A Novel Mechanism of Resistance to Penicillin-Gentamicin Synergism in Streptococcus faecalis The Journal of Infectious Diseases. ,vol. 141, pp. 81- 86 ,(1980) , 10.1093/INFDIS/141.1.81
SHINICHI KONDO, ATSUSHI TAMURA, SHUICHI GOMI, YOKO IKEDA, TOMIO TAKEUCHI, SUSUMU MITSUHASHI, Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus. The Journal of Antibiotics. ,vol. 46, pp. 310- 315 ,(1993) , 10.7164/ANTIBIOTICS.46.310
T. M. Coque, R. C. Arduino, B. E. Murray, High-Level Resistance to Aminoglycosides: Comparison of Community and Nosocomial Fecal Isolates of Enterococci Clinical Infectious Diseases. ,vol. 20, pp. 1048- 1051 ,(1995) , 10.1093/CLINIDS/20.4.1048